Cite

    Panés, J., Rubin, D., Vermeire, S., Lindsay, J., Sands, B., Su, C., Friedman, G., Zhang, H., Kayhan, C., Manuchehri, A., & Healey, P. (n.d.). aODWE-004 Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis. Gut, 66, A121–A122. http://access.bl.uk/ark:/81055/vdc_100144731534.0x00003f